Long-term Safety Study of Alogliptin Used in Combination With Sulfonylurea or Metformin in Participants With Type 2 Diabetes in Japan

NCT01318135 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

576

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Alogliptin and glimepiride
DRUG: Alogliptin and glimepiride
DRUG: Alogliptin and metformin
DRUG: Alogliptin and metformin

Sponsor

Takeda